Acute Coronary Syndrome in Alpha-Gal Syndrome: A Rare Immune-Cardiac Intersection Authors: Wongelawit Zerihun, Bersabel Tewodros, Joud Fahed, Abdul Mohammad, Ammer Bekele Published: 2026 ABSTRACT Alpha-gal syndrome (AGS) is an IgE-mediated hypersensitivity reaction to galactose-α-1,3-galactose (alpha-gal) following exposure to lone star tick bites. While classically associated with anaphylactic and delayed gastrointestinal-predominant allergic reactions to mammalian meat products, emerging evidence suggests an association between alpha-gal sensitization and accelerated coronary atherosclerosis. This case is presented to highlight the potential cardiovascular implications of AGS and its impact on acute coronary syndrome presentation and management.We report a case of a 51-year-old man with a medical history significant only for AGS who presented with a two-day history of severe retrosternal chest pain radiating to the left shoulder. Electrocardiography revealed ST-segment elevations in the inferior leads and severely elevated high-sensitivity troponin levels, prompting activation of an ST-elevation myocardial infarction protocol. Emergent coronary angiography revealed a 100% occlusion of the distal right coronary artery and a 90% stenosis of a marginal artery. Successful percutaneous coronary intervention was performed, followed by a staged intervention guided by intravascular ultrasound. Given the patient’s AGS, bivalirudin was used for anticoagulation to avoid porcine- or bovine-derived heparin products.This case supports a growing body of evidence linking AGS with coronary atherosclerosis and acute coronary syndrome. It highlights AGS as a potential isolated risk factor for coronary artery disease and underscores the importance of individualized diagnostic and therapeutic decision-making in affected patients. Introduction Alpha-gal syndrome (AGS) is an IgE-mediated hypersensitivity reaction to galactose-α-1,3-galactose, a carbohydrate found in non-primate mammalian meat products, most commonly following exposure in the United States to the lone star tick (Amblyomma americanum). It is most common across the southern, midwestern, and mid-Atlantic United States. According to the Centers for Disease Control and Prevention (CDC), sensitization rates exceed 35% in some endemic areas [1]. Despite this considerable burden, AGS remains markedly underdiagnosed, and many clinicians lack familiarity with its clinical presentation and broader implications [2]. While AGS is classically associated with delayed anaphylaxis, urticaria, and gastrointestinal symptoms, emerging evidence suggests a potential link between alpha-gal sensitization and accelerated coronary atherosclerosis, including increased non-calcified plaque burden and unstable atheroma [2,3]. Recent observational and mechanistic studies have suggested an association between alpha-gal-specific IgE antibodies and obstructive coronary artery disease, particularly in younger patients without traditional cardiovascular risk factors [3]. The scientific rationale for publishing this case is to highlight AGS as a potential isolated risk factor for acute coronary syndrome and to emphasize its implications for diagnostic evaluation and therapeutic decision-making in clinical practice. Case presentation A 51-year-old man with a medical history notable only for AGS presented to the emergency department with a two-day history of progressively worsening intermittent retrosternal chest pain. The pain was severe, sharp in quality, radiated to the left shoulder, and lasted up to two hours per episode without relief from rest. On arrival, he remained hemodynamically stable but continued to experience active chest pain. A 12-lead electrocardiogram demonstrated ST-segment elevations in the inferior leads (Figure 1). High-sensitivity cardiac troponin peaked at 3,600 ng/L. A diagnosis of ST-elevation myocardial infarction was established, and a STEMI alert was activated. The patient was taken emergently to the cardiac catheterization laboratory. Coronary angiography revealed a 100% occlusion of the distal right coronary artery and a 90% stenosis of a marginal branch (Figures 2A,B). Successful percutaneous coronary intervention (PCI) of the right coronary artery was performed. The procedure was complicated by a prolonged episode of bradycardia and hypotension following sheath removal, initially suspected to be vasovagal. Due to the persistence of symptoms, repeat angiography was performed, confirming the previously identified marginal artery lesion. A staged PCI of this lesion was subsequently completed successfully with intravascular ultrasound guidance. Post-procedural transthoracic echocardiography demonstrated preserved left ventricular systolic function (ejection fraction 55-60%) with no regional wall motion abnormalities and normal diastolic function. No significant valvular abnormalities were identified. Twelve-lead electrocardiogram showing ST-segment elevations in the inferior leads II, III, and aVF, marked by black arrows, consistent with an acute inferior ST-elevation myocardial infarction. Coronary angiography demonstrating a severe (90%) stenosis of the marginal artery (A) and 100% occlusion of the distal right coronary artery (B) prior to intervention. Given his history of AGS, bivalirudin was selected for anticoagulation to avoid exposure to mammalian-derived heparin products. Although enoxaparin was considered due to its lower sensitization risk, bivalirudin was preferred based on its more established safety profile in patients with AGS. Further evaluation, including thyroid function testing, lipid panel, and toxicology screening, did not reveal alternative etiologies for premature coronary artery disease. The patient had no history of hypertension, diabetes mellitus, hyperlipidemia, tobacco use, alcohol consumption, or illicit drug use. He had a body mass index of 28 kg/m² and reported an active lifestyle, including daily bicycling. There was no family history of premature coronary artery disease, and he was not taking any chronic medications. As stated above, his past medical history was notable for AGS. He was diagnosed two years prior to his coronary event after a tick bite sustained during a camping trip, which he had initially considered benign. Approximately four weeks following the exposure, he developed abdominal discomfort, rash, and anxiety after ingestion of beef and dairy products, ultimately progressing to a severe anaphylactic reaction requiring hospitalization. Subsequent outpatient immunologic evaluation confirmed the diagnosis, demonstrating elevated beef-specific IgE (0.5 kU/L; normal <0.1 kU/L), alpha-gal IgE (12.8 kU/L; normal <0.1 kU/L), and a borderline elevation of cow’s milk IgE (0.35 kU/L; normal <0.35 kU/L). He was counseled to adhere to strict avoidance of mammalian-derived products, including red meat and certain medications, and to additionally eliminate dairy products in light of the borderline elevation in milk-specific IgE in the immunologic work-up and his prior history of life-threatening anaphylaxis. The rest of the hospital course was otherwise uncomplicated. He was discharged in stable condition with follow-up arranged with cardiology and immunology. Discussion This case describes acute coronary syndrome occurring in a patient with AGS in the absence of traditional cardiovascular risk factors. The patient’s active lifestyle and lack of family history or other risk factors for coronary artery disease further support AGS as the most plausible contributing risk factor. Emerging evidence suggests that alpha-gal-specific IgE antibodies may contribute to vascular inflammation and plaque instability through immune-mediated mechanisms [3]. Sensitization to α-gal-specific IgE may be associated with increased atherosclerotic plaque burden and higher-risk plaque features, particularly in younger patients, independent of traditional cardiovascular risk factors, thought to occur through chronic mast cell-mediated inflammation triggered by dietary α-gal-containing lipids within vascular plaques [4]. Observational studies have demonstrated an association between alpha-gal sensitization and increased burden of noncalcified coronary plaque, obstructive coronary artery disease, and unstable atheroma, particularly in patients younger than 65 years. Immunohistologic analyses have identified alpha-gal epitopes within human atherosclerotic plaques, supporting a biologically plausible link between chronic IgE-mediated immune activation and accelerated atherogenesis [5-7]. In one prospective study of over 100 patients undergoing coronary catheterization, the presence of alpha-gal-specific IgE was associated with significantly greater atheroma burden and high-risk plaque morphology, including increased calcification, fibrofatty content, and necrotic core volume, all of which are features of vulnerable plaque known to predict adverse cardiovascular outcomes [8]. Beyond its potential etiologic role, AGS significantly influenced clinical management in this case. Anticoagulation with bivalirudin was selected to mitigate the risk of hypersensitivity reactions associated with porcine- or bovine-derived heparin products, which have been reported in patients with alpha-gal allergy. Enoxaparin, which is a porcine intestinal mucosa-derived medication, is another lower-allergic-risk anticoagulation option but still contains detectable levels of alpha-gal protein and may carry a small risk of sensitization, especially in those with higher alpha-gal IgE titers [8]. Additionally, heightened caution was required when initiating guideline-directed medical therapy, including statins and other medications that may contain mammalian-derived excipients, underscoring the practical challenges encountered in the acute management of cardiovascular disease in this population [9-11]. This case contributes to the growing literature suggesting that AGS may represent an underrecognized cardiovascular risk factor. Further prospective and mechanistic studies are needed to better define this relationship and to determine whether targeted screening or preventive strategies are warranted. Conclusions This case adds to a growing body of evidence linking AGS with coronary atherosclerosis and acute coronary syndrome. AGS may represent an underrecognized isolated risk factor for coronary artery disease and should be considered in patients presenting with acute coronary syndrome in the absence of traditional risk factors. Recognition of this condition has important implications for diagnostic evaluation and therapeutic decision-making. Further research is needed to better define the cardiovascular risks associated with alpha-gal sensitization.